Unless this takes more than 6 months to sort and who knows they may actually become more efficient, this shouldn’t affect us. The IRB has given the go ahead and they are the proxy for the FDA relating to NSR trial commencement. So for now it’s time to get on with the trial and start collecting data. Imminent news flow will come as expected. As you well know Michael, short term noise in a long term project often throws up opportunities.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)